FILIZ JUNGE: Open Payments
NPI 1457026551 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 16 payments from 11 companies in 2025. Trend: 2023 $14 · 2024 $666 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation | 3 | $135 |
| Celgene Corporation | 2 | $76 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| GENZYME CORPORATION | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $24 |
| Legend Biotech USA Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Syndax Pharmaceuticals, Inc. | 1 | $20 |
| Teleflex LLC | 1 | $14 |
Products named: RYTELO, REBLOZYL, LYNOZYFIC, CARVYKTI, BREYANZI, SARCLISA, TECVAYLI, Venclexta.
Industry payments across SD — which companies pay providers there.
